🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

UFP Technologies, Inc. UFPT R2K

Healthcare · Medical Devices · United States
https://www.ufpt.com

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

READ MORE ›
$220.10
-6.02% 1Y

Market & Price

Market Cap
$1.70B
Current Price
$220.10
High / Low (52W)
$267.56 / $185.28
Beta
1.08

Valuation

Stock P/E
25.07
Industry PE
23.65
Forward P/E
18.83
PEG Ratio
3.80
Book Value
$54.95
Price to Book
4.01
P/S
2.80
EV/EBITDA
16.37
Dividend Yield
-

Profitability & Returns

ROCE
15.91%
ROE
17.17%
ROA
8.81%
Profit Margin
11.27%
Op Margin
15.14%
EPS (Latest Qtr)
$2.24
EPS (TTM)
$8.78

Balance Sheet & Liquidity

Debt/Equity
0.36
Quick Ratio
1.59
Current Ratio
2.91
Debt
$156.07M
Total Assets
$655.08M
Current Assets
$201.00M
Working Capital
$126.14M

Ownership

Promoter Holding
3.90%
Chg in Prom Hold
-
FII / Inst Holding
116.90%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
$1.84B
Total Revenue (TTM)
$608.85M
EBITDA
$112.36M
Free Cash Flow
$53.57M
Operating Cash Flow
$81.30M
Shares Outstanding
7.74M
Gross Margin
28.35%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
19.44%
Profit 5Y
17.80%
Revenue (YoY)
4.10%
Earnings (YoY)
1.40%

PROS

  • Compounding revenue at 19.4% over 5 years.
  • Profit CAGR of 17.8% over 5 years.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 UFPT UFP Technologies, Inc. R2K 220.10 25.07 $1.70B - 15.91% 17.17% 19.44% 17.80%
2 LLY Eli Lilly and Company SPX 1,105.00 39.21 $985.37B 0.63% 38.44% 107.46% 31.69% 48.96%
3 JNJ Johnson & Johnson SPX 225.33 26.11 $542.42B 2.38% 23.13% 26.42% 5.60% 14.32%
4 UNH UnitedHealth Group Incorporated SPX 380.31 28.66 $345.38B 2.32% 9.60% 12.18% 11.35% -15.69%
5 MRK Merck & Co., Inc. SPX 118.72 33.44 $293.22B 2.86% 20.66% 18.94% 3.12% 7.93%
6 TMO Thermo Fisher Scientific Inc. SPX 492.51 27.11 $183.03B 0.38% 9.17% 13.52% -0.27% -1.19%
7 AMGN Amgen Inc. NDXSPX 336.79 23.42 $181.77B 2.99% 18.02% 101.32% 11.77% 5.58%
8 GILD Gilead Sciences, Inc. NDXSPX 134.43 18.29 $166.90B 2.44% 22.92% 43.36% 2.57% 22.83%
9 ISRG Intuitive Surgical, Inc. NDXSPXAI 424.64 51.53 $150.39B - 15.96% 17.23% 17.39% 29.26%
Ad space

Quarterly Results

Figures in USD.

Metric Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ---------------------------97.75M100.04M100.78M101.50M105.01M110.18M145.16M144.07M148.15M151.18M154.56M148.91M154.20M
Cost of Revenue -----------------------------------106.00M107.63M111.81M106.95M109.84M
Gross Profit 10.29M8.45M8.18M9.52M9.94M8.19M7.84M10.19M12.99M12.43M12.71M12.50M14.37M13.32M13.77M12.82M9.95M10.53M11.38M12.61M13.41M12.02M13.07M17.13M24.32M25.52M23.28M28.70M29.64M27.75M26.13M30.08M33.03M41.52M42.06M42.15M43.54M42.75M41.97M44.36M
Operating Expenses -----------------------------------18.73M18.68M19.07M20.96M21.02M
Operating Income 4.19M4.08M-3.21M3.93M2.50M-2.56M5.67M5.88M-5.25M6.57M6.14M-5.08M2.99M3.73M-5.30M6.21M5.08M-6.36M12.20M25.96M-12.84M17.04M15.04M-15.92M17.95M24.76M-23.43M24.86M23.68M21.00M23.34M
EBITDA -----------------------------------27.72M29.02M28.33M26.40M28.24M
Interest Expense -----------------------------------2.81M2.67M2.39M1.93M1.74M
Pretax Income -----------------------------------20.28M21.63M21.06M19.54M21.61M
Tax Provision -----------------------------------3.10M4.45M4.68M1.98M4.11M
Net Income 2.73M2.67M-2.17M2.63M1.70M-1.78M3.99M4.13M-3.73M4.60M5.64M-3.89M2.32M2.99M-4.16M4.71M3.79M-4.86M8.93M19.54M-9.74M11.88M11.69M11.61M12.69M13.55M16.36M16.38M17.18M17.18M16.38M17.57M17.50M
Diluted EPS 0.380.370.200.300.360.230.370.240.540.560.590.000.620.750.770.520.310.400.550.550.620.500.420.641.172.561.101.271.551.521.511.641.752.112.102.212.212.112.252.24

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -------------353.79M400.07M504.42M602.80M
Cost of Revenue -------------263.53M287.85M357.73M432.39M
Gross Profit 26.72M34.62M36.24M38.32M41.01M36.88M37.45M34.65M35.49M48.31M53.96M44.68M-90.26M112.22M146.69M170.41M
Operating Expenses -------------45.80M50.89M62.22M77.44M
Operating Income 8.19M14.39M15.72M16.67M17.40M11.56M11.71M12.24M11.69M19.61M24.71M16.73M-44.46M61.34M84.47M92.97M
EBITDA -------------67.37M68.95M95.80M111.47M
Interest Expense -------------2.76M3.65M8.06M9.80M
Pretax Income -------------52.72M53.90M73.03M82.51M
Tax Provision -------------10.93M8.98M14.04M14.20M
Net Income ----11.28M7.56M7.59M7.97M9.21M14.31M19.75M13.37M-41.79M44.92M58.98M68.31M
Diluted EPS 0.941.371.481.551.591.051.051.101.261.932.631.77-5.455.837.588.75
R&D Expense -900.00K1.20M1.30M1.20M1.40M1.30M1.30M5.00M10.50M8.80M8.20M8.50M9.30M7.20M10.40M8.60M

Compounded Sales Growth

5 Years:19.44%
1 Year:4.10%

Compounded Profit Growth

5 Years:17.80%
1 Year:1.40%

Stock Price Performance

1 Year:-6.02%
6 Months:-4.20%
3 Months:+4.52%
1 Month:+18.68%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --69.48M79.72M98.62M104.91M112.55M119.64M127.93M138.21M189.60M188.76M203.20M-378.19M404.14M629.00M655.08M
Current Assets --------------116.35M144.63M194.94M201.00M
Cash & Equivalents 5.14M13.40M22.10M29.85M33.48M37.30M34.05M29.80M31.36M37.98M3.24M3.74M24.23M-4.45M5.26M13.45M20.30M
Inventory --------------53.54M70.19M87.54M86.86M
Receivables --------------55.12M64.45M84.68M82.91M
Total Liabilities --19.25M17.74M25.36M19.32M17.56M16.06M14.88M14.49M49.14M26.77M26.31M-140.65M118.05M286.24M231.20M
Current Liabilities --10.17M9.47M13.23M12.32M11.61M10.67M9.56M9.94M20.66M16.78M15.14M-55.96M58.21M76.30M74.86M
Long Term Debt --6.85M5.64M8.31M2.87M1.87M859.00K--22.29M-0-51.00M28.00M176.88M122.95M
Total Debt --------------68.37M46.04M206.03M154.48M
Total Equity --49.70M61.31M73.26M85.59M94.99M103.57M113.05M123.71M140.46M161.99M176.89M-237.54M286.09M342.76M423.88M
Shares Outstanding --------------7.61M7.67M7.71M7.74M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow ------12.52M9.31M17.47M21.32M31.23M25.04M-17.74M41.33M66.59M91.91M
Investing Cash Flow -------15.69M-7.19M-10.38M-82.33M-5.77M-4.26M-1.29M-10.49M-210.16M-27.60M
Financing Cash Flow -------1.08M-559.00K-475.00K26.27M-24.95M-285.00K--25.89M-30.02M152.39M-58.16M
Capital Expenditure -1.86M-3.29M-3.74M-11.99M-5.83M-13.44M-15.74M-7.21M-10.38M-5.43M-5.78M-4.37M--13.78M-10.49M-9.66M-12.93M
Free Cash Flow -------3.22M2.10M7.09M15.89M25.45M20.67M-3.96M30.84M56.94M78.98M
Net Change in Cash --------------6.86M822.00K8.82M6.15M
Share Buybacks ------587.00K----------

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------------25.5%28.1%29.1%28.3%
Operating Margin % -------------12.6%15.3%16.7%15.4%
Net Margin % -------------11.8%11.2%11.7%11.3%
ROE % ----13.2%8.0%7.3%7.0%7.4%10.2%12.2%7.6%-17.6%15.7%17.2%16.1%
ROCE % -24.3%22.4%19.5%18.8%11.5%10.8%10.3%9.1%11.6%14.4%8.9%-13.8%17.7%15.3%16.0%

Shareholding Pattern

Insiders
3.90%
Institutions
116.90%
Public Float
121.64%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 14.18% 1.10M $241.49M
2 Wasatch Advisors LP 10.05% 777.31K $171.09M
3 Congress Asset Management Co 6.77% 523.44K $115.21M
4 Vanguard Capital Management LLC 4.22% 326.73K $71.91M
5 Boston Trust Walden Corporation 4.10% 317.07K $69.79M
6 State Street Corporation 3.92% 303.31K $66.76M
7 Neuberger Berman Group, LLC 3.89% 300.59K $66.16M
8 Price (T.Rowe) Associates Inc 3.19% 246.50K $54.26M
9 Thrivent Financial For Lutherans 3.07% 237.28K $52.22M
10 Massachusetts Financial Services Co. 2.94% 227.30K $50.03M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for UFPT

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks